NASDAQ:AUPH - Aurinia Pharmaceuticals Inc.
$6.60
 $0.03
+0.46%
2:10PM EDT
2019-02-15
Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead compound voclosporin, a therapeutic immunomodulating drug candidate, which is a second-generation calcineurin inhibitors (CNI) to treat patients afflicted with LN. Voclosporin is an oral drug, administered twice daily. It is structurally similar to cyclosporine A (CsA), but is chemically modified on the amino acid-1 residue. It has completed two Phase III clinical studies in patients with moderate to severe psoriasis. It has completed Phase IIb clinical trial, which is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active LN. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  AUPH     avg for
industry  
  avg for
sector  
42 stocks weight:  124. 20   0. 00   0. 00  
42 stocks rank:  1. 52 K 1. 86 K 1. 09 K
# analyst opinions:  6. 00   14. 92   14. 43  
mean recommendation:  1. 70   1. 91   1. 93  

quick ratio:  20. 29   5. 37   1. 81  
current ratio:  20. 93   5. 69   2. 19  

target price low:  10. 00   88. 97   117. 82  
target price avg:  11. 92   115. 19   141. 96  
target price high:  14. 00   143. 40   163. 16  
1-yr high:  7. 64   124. 30   142. 77  
last close:  6. 57   101. 85   127. 84  
50-day avg:  6. 48   98. 27   122. 46  
200-day avg:  5. 85   99. 72   122. 70  
1-yr low:  5. 06   78. 19   100. 16  
volume:  328. 10 K 2. 38 M 4. 64 M
50-day avg volume:  990. 36 K 3. 31 M 4. 94 M
200-day avg volume:  632. 43 K 3. 23 M 4. 28 M

1-day return:  2. 34 % 0. 22 % 0. 48 %
this week return:  0. 46 % 1. 77 % 2. 01 %
12-wk return:  21. 67 % 6. 56 % 3. 33 %
52-wk return:  25. 53 % -2. 23 % 14. 35 %

enterprise value (EV):  419. 26 M 55. 17 B 104. 51 B
market cap:  552. 02 M 49. 01 B 96. 46 B
EBITDA:  -52. 58 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -7. 97   -91. 79   2. 29  
enterprise/revenue (EV/R):  899. 70   29. 84   23. 39  
total revenue:  466. 00 K 11. 28 B 40. 22 B
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -52. 86 M 2. 37 B 3. 58 B

shares outstanding:  85. 34 M 607. 99 M 1. 22 B
shares:  61. 43 M 605. 53 M 1. 15 B
shares short:  6. 41 M 11. 62 M 12. 55 M
shares short prior month:  7. 41 M 11. 95 M 13. 44 M
short ratio:  8. 40   4. 82   3. 10  
total cash/share:  1. 63   12. 02   11. 46  
total cash:  138. 88 M 7. 41 B 7. 37 B
free cash flow:  -28. 38 M 95. 99 M 2. 04 B
operating cash flow:  -46. 93 M 164. 74 M 3. 04 B

book value:  1. 47   14. 43   28. 26  
price/book:  4. 47   -1. 57   -2. 97  
gross profits:  -33. 51 M 8. 28 B 18. 09 B
operating margins:  -11620. 82 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  12. 52 % --- ---
1-yr mean volatility:  0. 13 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 63   3. 03   4. 09  
forward EPS:  -0. 55   4. 33   6. 99  
P/E:  -10. 50   6. 11   26. 91  
forward P/E:  -12. 00   8. 38   10. 48  
PE/G:  -0. 01   0. 37   5. 61  
growth:  1193. 10 % 683. 72 % 104. 79 %
earnings high:  -0. 08   1. 27   1. 66  
earnings avg:  -0. 15   1. 01   1. 53  
earnings low:  -0. 19   0. 76   1. 40  
revenue high:  100. 00 K 2. 86 B 11. 19 B
revenue avg:  50. 00 K 2. 78 B 10. 84 B
revenue low:  30. 00 K 2. 67 B 10. 64 B
return on assets:  -18. 93 % -3. 27 % 3. 81 %
return on equity:  -36. 08 % 107. 48 % 27. 82 %
revenue growth:  1193. 10 % 648. 36 % 97. 70 %
revenue/share:  0. 01   14. 68   59. 83  

beta (1yr vs S&P500):  0. 68   1. 21   0. 93  
sharpe (1yr):  0. 71   0. 06   0. 98  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : AUPH
.    + 1.937 =         1.937 :: INITIAL WEIGHT
.  + 157.275 =       159.212 :: inverse volume-to-price addition
.  + 523.701 =       682.913 :: spline projection addition
.  - 110.382 =       572.531 :: poor performance penalty
.    x 1.251 =       716.482 :: one-year gains+dividend factor
.    x 4.189 =      3000.987 :: 13 weeks' performance factor
.    x 1.492 =       4478.94 :: industry recommendation factor
.    x 2.565 =     11488.921 :: symbol recommendation factor
.    x 5.418 =     62241.394 :: EV/R factor
.    x 0.998 =     62123.552 :: return on assets factor
.    x 0.996 =     61899.392 :: return on equity factor
.     x 2.34 =    144845.526 :: revenue growth factor
.     x 3.81 =    551933.059 :: current ratio factor
.    x 1.026 =    566062.118 :: quick ratio factor
.    x 1.058 =    598809.079 :: short ratio factor
.    x 2.045 =   1224399.475 :: price-to-book factor
.    x 1.115 =   1365205.967 :: 5-day avg > 200-day avg
.    x 1.006 =    1373503.42 :: 5-day avg > 50-day avg
.    x 1.108 =   1522205.269 :: 50-day avg > 200-day avg
.    x 2.106 =   3205407.911 :: P/E weight
.    x 2.209 =   7080615.017 :: PE/G factor
.    x 1.708 =  12093025.788 :: beta factor
.    x 0.711 =   8600157.531 :: sharpe factor
.    x 1.778 =  15286796.295 :: target low factor
.    x 1.301 =  19885012.947 :: target mean factor
.    x 1.106 =  21999658.582 :: target high factor
.    x 1.066 =  23443117.931 :: industry 12-weeks return
.    x 0.991 =  23236572.716 :: "drift" penalty 1 days ago
.      x 1.0 =  23236338.645 :: overall "drift" factor
.    x 0.875 =  20327012.268 :: largest single-day jump factor
.    x 0.094 =   1915835.275 :: low price factor
.      x 1.0 =   1915963.871 :: factor hist industry gain for week 06
.   cubeRoot =       124.202 :: reduced for readability
.                    124.202 :: FINAL WEIGHT for NASDAQ:AUPH


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org